Wen, H.; Poutiainen, P.; Batnasan, E.; Latonen, L.; Lehto, V.-P.; Xu, W.
Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer. Pharmaceutics 2023, 15, 2507.
https://doi.org/10.3390/pharmaceutics15102507
AMA Style
Wen H, Poutiainen P, Batnasan E, Latonen L, Lehto V-P, Xu W.
Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer. Pharmaceutics. 2023; 15(10):2507.
https://doi.org/10.3390/pharmaceutics15102507
Chicago/Turabian Style
Wen, Huang, Pekka Poutiainen, Enkhzaya Batnasan, Leena Latonen, Vesa-Pekka Lehto, and Wujun Xu.
2023. "Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer" Pharmaceutics 15, no. 10: 2507.
https://doi.org/10.3390/pharmaceutics15102507
APA Style
Wen, H., Poutiainen, P., Batnasan, E., Latonen, L., Lehto, V.-P., & Xu, W.
(2023). Biomimetic Inorganic Nanovectors as Tumor-Targeting Theranostic Platform against Triple-Negative Breast Cancer. Pharmaceutics, 15(10), 2507.
https://doi.org/10.3390/pharmaceutics15102507